Skip to main navigation
Fulcrum Therapeutics logo
Menu Button

Main Menu

  • About
  • Our Approach
  • Pipeline
    • Publications
  • Therapeutic Focus
    • FSHD
    • SCD
    • Beta-thalassemia
  • Careers
    • Current Openings
    • Faces of Fulcrum
  • Investor Relations
    • News Releases
    • Events and Presentations
    • Stock Information
    • SEC Filings
    • Corporate Governance
    • Investor FAQs
  • Contact

Compensation & Human Capital Management Committee

Compensation & Human Capital Management Committee 153.6 KB
Alan Ezekowitz, MBChB, D.Phil Katina Dorton Rachel King
  • Member
  • Chair
  • Financial Expert
  • Independent Director

Investor Tools

Print
Email Page
Email Alerts
IR Contact
Code of Conduct & Business Ethics
Privacy Policy | EU Privacy Policy | Terms of use
Fulcrum TX
Social Media Guidelines

Main Menu

  • About
  • Our Approach
  • Pipeline
    • Publications
  • Therapeutic Focus
    • FSHD
    • SCD
    • Beta-thalassemia
  • Careers
    • Current Openings
    • Faces of Fulcrum
  • Investor Relations
    • News Releases
    • Events and Presentations
    • Stock Information
    • SEC Filings
    • Corporate Governance
    • Investor FAQs
  • Contact